Seoul, South Korea

Seol Hwa Shin

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Ulsan Foundation for Industry Cooperation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seol Hwa Shin. Retrieved from https://idiyas.com/inventor/seol-hwa-shin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Seol Hwa Shin

Introduction

Seol Hwa Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the area of cancer treatment. His innovative work focuses on developing targeted therapies that can improve patient outcomes.

Latest Patents

Seol Hwa Shin holds a patent for "Peptides for targeting gastric cancer, and medical use thereof." This patent describes a peptide designed to target gastric cancer effectively. The invention includes a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, as well as a drug delivery method utilizing the peptide. This functional peptide aims to facilitate personalized diagnosis and treatment for individual patients, taking into account the varying therapeutic responses due to genetic differences among patients.

Career Highlights

Seol Hwa Shin is affiliated with the University of Ulsan Foundation for Industry Cooperation. His work at this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Some of his notable coworkers include Eun Kyung Choi and Seong-Yun Jeong. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Seol Hwa Shin's contributions to cancer treatment through his patented innovations highlight the importance of personalized medicine. His work continues to pave the way for more effective therapies that can significantly improve the lives of cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…